Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiemesis.

× No keyword cloud information.

17 in total

1. Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204.

Authors: Dana M Chase; James Kauderer; Lari Wenzel; Lois Ramondetta; David Cella; Harry J Long; Bradley J Monk
Journal: Int J Gynecol Cancer Date: 2015-02 Impact factor: 3.437

2. Efficacy of aprepitant in preventing nausea and vomiting due to high-dose melphalan-based conditioning for allogeneic hematopoietic stem cell transplantation.

Authors: Masatoshi Sakurai; Takehiko Mori; Jun Kato; Yuya Koda; Taku Kikuchi; Sumiko Kohashi; Masuho Saburi; Takaaki Toyama; Yoshinobu Aisa; Tomonori Nakazato; Noriko Beppu; Soichiro Tsuda; Naoyuki Shigematsu; Shinichiro Okamoto
Journal: Int J Hematol Date: 2014-03-12 Impact factor: 2.490

3. Dexamethasone exacerbates cytotoxic chemotherapy induced lethargy and weight loss in female tumor free mice.

Authors: John Wong; Lisa T Tran; Kaari A Lynch; Lisa J Wood
Journal: Cancer Biol Ther Date: 2017-12-12 Impact factor: 4.742

4. Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster.

Authors: Carlo Pirri; Evan Bayliss; James Trotter; Ian N Olver; Paul Katris; Peter Drummond; Robert Bennett
Journal: Support Care Cancer Date: 2012-09-14 Impact factor: 3.603

5. A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy.

Authors: Kenjiro Aogi; Hiroshi Sakai; Hirohisa Yoshizawa; Norikazu Masuda; Nobuyuki Katakami; Yasuhiro Yanagita; Kenichi Inoue; Masaru Kuranami; Mitsuhiro Mizutani; Noriyuki Masuda
Journal: Support Care Cancer Date: 2011-08-02 Impact factor: 3.603

6. Patterns of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting in China.

Authors: Xianglong Zong; Jie Zhang; Xin Ji; Jie Gao; Jiafu Ji
Journal: Chin J Cancer Res Date: 2016-04 Impact factor: 5.087

7. Aprepitant plus granisetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.

Authors: Katsunobu Oyama; Sachio Fushida; Masahide Kaji; Toshiya Takeda; Shinichi Kinami; Yasuo Hirono; Katsuhiro Yoshimoto; Kazuhisa Yabushita; Hisashi Hirosawa; Yuki Takai; Tatsuo Nakano; Hironobu Kimura; Toshiaki Yasui; Atsushi Tsuneda; Tomoya Tsukada; Jun Kinoshita; Takashi Fujimura; Tetsuo Ohta
Journal: J Gastroenterol Date: 2013-01-22 Impact factor: 7.527

Review 8. Quality-of-life issues in the management of epithelial ovarian cancer.

Authors: Thomas Lowe; Betty Ferrell; Lucille Leong
Journal: Curr Treat Options Oncol Date: 2007-12

9. Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy.

Authors: Steven M Grunberg; Matthew Dugan; Hyman Muss; Marie Wood; Susan Burdette-Radoux; Tracey Weisberg; Marisa Siebel
Journal: Support Care Cancer Date: 2008-11-27 Impact factor: 3.603

10. Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.

Authors: Paul J Hesketh; Jerry Younger; Pedro Sanz-Altamira; Melissa Hayden; Julie Bushey; Brian Trainor; Michael Krentzin; Peter Nowd; Konstantinos Arnaoutakis; Ann M Hesketh
Journal: Support Care Cancer Date: 2008-12-06 Impact factor: 3.603